Diisopropylethylamine → HCID 117697825, compound
Reaction equation
[CH3:1][O:2][C:3]([CH:5]1[CH2:12][CH:11]2[NH:13][CH:7]([CH2:8][O:9][CH2:10]2)[CH2:6]1)=[O:4].[CH3:14][O:15][C:16]([C:18]1[C@H:19]([C:31]2[CH:36]=[CH:35][C:34]([F:37])=[CH:33][C:32]=2[Cl:38])[N:20]=[C:21]([C:26]2[S:27][CH:28]=[CH:29][N:30]=2)[NH:22][C:23]=1[CH2:24]Br)=[O:17].CCN(C(C)C)C(C)C>C(Cl)CCl.CCOC(C)=O>[Cl:38][C:32]1[CH:33]=[C:34]([F:37])[CH:35]=[CH:36][C:31]=1[C@H:19]1[C:18]([C:16]([O:15][CH3:14])=[O:17])=[C:23]([CH2:24][N:13]2[CH:7]3[CH2:6][CH:5]([C:3]([O:2][CH3:1])=[O:4])[CH2:12][CH:11]2[CH2:10][O:9][CH2:8]3)[NH:22][C:21]([C:26]2[S:27][CH:28]=[CH:29][N:30]=2)=[N:20]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a stirred solution 3-oxa-9-azabicyclo[3.3.1]nonane-7-carboxylic acid methyl ester (90 mg, 0.48 mmol) (PharmaBlock (Nanjing) R&D Co. Ltd, CAS: 1363382-76-6) and (R)-6-bromomethyl-4-(2-chloro-4-fluoro-phenyl)-2-thiazol-2-yl-1,4-dihydro-pyrimidine-5-carboxylic acid methyl ester (104 mg, 0.24 mmol) in ClCH2CH2Cl (5 mL) was added DIPEA (0.15 mL, 0.48 mmol) at room temperature. The reaction mixture was stirred overnight at room temperature, then diluted with EtOAc (60 mL), washed with sat. NH4Cl, sat. NaHCO3 and brine (20 mL) respectively. The organic layer was dried over Na2SO4, concentrated under reduced pressure to give methyl 9-[[(4R)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1,4-dihydropyrimidin-6-yl]methyl]-3-oxa-9-azabicyclo[3.3.1]nonane-7-carboxylate as a crude product which was used directly in next step.
Workup
- washwashed with sat. NH4Cl, sat. NaHCO3 and brine (20 mL) respectively
- dry with materialThe organic layer was dried over Na2SO4
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-c13d6bdbc285419784663402bfb80b29
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09266904B2
Reaction notes
Loading…